Ocugen (OCGN) Interest Expenses (2014 - 2026)

Ocugen (OCGN) reported Interest Expenses of $1.3 million for Q1 2026, up 5.01% on a YoY basis from $1.3 million in Q1 2025, and down 0.9% quarter-over-quarter from $1.3 million in Q4 2025.

Ocugen (OCGN) Interest Expenses (2014 - 2026) Analysis & Trends

Ocugen has reported Interest Expenses for 10 years, with the latest figure at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses rose 5.01% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (up 110.17% YoY), and the FY2025 full-year result was $5.2 million, up 654.07% from the prior year.
  • Interest Expenses for Q1 2026 stood at $1.3 million, down from $1.3 million in the prior quarter.
  • The five-year high for Interest Expenses was $1.3 million in Q4 2025, with the low at $29000.0 in Q3 2024.
  • Historically, Interest Expenses has averaged $975500.0 across 3 years, with a median of $1.3 million in 2025.
  • Annual changes were most pronounced in 2025 — Interest Expenses soared 4431.03% — and 2026, when it increased 5.01%.
  • Ocugen's Interest Expenses stood at $601000.0 in 2024, then surged by 121.63% to $1.3 million in 2025, then fell by 0.9% to $1.3 million in 2026.
  • The last three Interest Expenses figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Ocugen 411.07 Mn 411.07 Mn - 1.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.32 Mn
Mar 31, 2026 1.32 Mn
Dec 31, 2025 1.33 Mn
Dec 31, 2025 1.33 Mn
Sep 30, 2025 1.31 Mn
Sep 30, 2025 1.31 Mn
Mar 31, 2025 1.26 Mn
Mar 31, 2025 1.26 Mn
Dec 31, 2024 601,000.00
Dec 31, 2024 601,000.00
Sep 30, 2024 29,000.00
Sep 30, 2024 29,000.00
Dec 31, 2021 20,000.00
Dec 31, 2021 20,000.00
Sep 30, 2021 19,000.00
Sep 30, 2021 19,000.00
Jun 30, 2021 20,000.00
Jun 30, 2021 20,000.00
Mar 31, 2021 20,000.00
Mar 31, 2021 20,000.00